$50.39
-0.18-0.36%
Last update: Oct 30, 4:00 PM
Travere Therapeutics Inc (TVTX) Stock Price, Quote, News & History
TVTXNASDAQ
FTC and 7 states seek contempt against Martin Shkreli, alleging he violated his lifetime pharma ban by trading biotech stocks and influencing markets.
You can purchase shares of Travere Therapeutics (NASDAQ:TVTX) through any online brokerage.
Other companies in Travere Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Travere Therapeutics has a consensus price target of $50.22.
The stock price for Travere Therapeutics (NASDAQ: TVTX) is $50.39 last updated October 30, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Travere Therapeutics.
Travere Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Travere Therapeutics.
Travere Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is...
